Hispanic breast cancer patients’ symptom experience and patient-physician communication during chemotherapy
- 87 Downloads
Patient-clinician communication difficulties are a major barrier to effective symptom management during chemotherapy especially among non-English-speaking and minority patients. This study sought to examine how information is exchanged between patients and clinicians during chemotherapy treatment regarding pain, depression, fatigue, and nausea experienced among the most prevalent non-English-speaking group in the USA, Hispanic breast cancer survivors.
Hispanic breast cancer patients and clinicians participated in focus groups to examine Hispanic breast cancer survivors’ experience and patient-physician communication of symptoms during chemotherapy. Three separate focus groups (English language with patients, Spanish language with patients, and English language with clinicians) were conducted. All participants completed a demographic questionnaire.
Six breast cancer survivors participated in the English-language focus group, ten breast cancer survivors participated in the Spanish-language focus group, and five clinicians participated. Presence and communication of depressive symptoms between the English- and Spanish-language groups differed, with the majority of the English-language group sharing their experiences of depressive symptoms while those in the Spanish-language group did not report depressive symptoms. Results also indicated that most patients were unhappy with the response of clinicians regarding their reported symptoms. Several barriers to effective patient-clinician communication, including limited physician time, lack of patient knowledge, timidity, and language, were identified.
The findings of this study underscore the need to improve patient-physician communication during chemotherapy to reduce the symptom burden among Hispanic breast cancer patients.
KeywordsHispanic Breast cancer Patient-physician communication Symptoms Chemotherapy
We would also like to acknowledge the breast cancer survivors and clinicians who were part of our focus groups.
Compliance with ethical standards
Informed consent procedures and study protocols were approved by the Institutional Review Boards of the participating clinics and universities.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.American Cancer Society (2015) Cancer facts & figures for Hispanic/Latinos 2015–2017. American Cancer Society, AtlantaGoogle Scholar
- 23.Ashing-Giwa KT, Padilla G, Tejero J, Kraemer J, Wright K, Coscarelli A, Clayton S, Williams I, Hills D (2004) Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psycho-Oncology 13(6):408–428PubMedPubMedCentralCrossRefGoogle Scholar
- 33.Epstein RM, Duberstein PR, Fenton JJ, Fiscella K, Hoerger M, Tancredi DJ, Xing G, Gramling R, Mohile S, Franks P, Kaesberg P, Plumb S, Cipri CS, Street RL Jr, Shields CG, Back AL, Butow P, Walczak A, Tattersall M, Venuti A, Sullivan P, Robinson M, Hoh B, Lewis L, Kravitz RL (2017) Effect of a patient-centered communication intervention on oncologist-patient communication, quality of life, and health care utilization in advanced cancer: the VOICE randomized clinical trial. JAMA Oncology 3(1):92–100PubMedPubMedCentralGoogle Scholar
- 34.Epstein RM, Street RL Jr (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. National Cancer Institute, Bethesda, pp 07–6225Google Scholar
- 35.Mandelblatt JS, Sheppard VB, Hurria A, Kimmick G, Isaacs C, Taylor KL, Kornblith AB, Noone AM, Luta G, Tallarico M, Barry WT, Hunegs L, Zon R, Naughton M, Winer E, Hudis C, Edge SB, Cohen HJ, Muss H, Cancer Leukemia Group B (2010) Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol 28(19):3146–3153PubMedPubMedCentralCrossRefGoogle Scholar
- 39.Post DM, Shapiro CL, Cegala DJ, David P, Katz ML, Krok JL, Phillips GS, McAlearney AS, Lehman JS, Hicks W, Paskett ED (2013) Improving symptom communication through personal digital assistants: the CHAT (Communicating Health Assisted by Technology) project. J Natl Cancer Inst Monogr 2013(47):153–161PubMedPubMedCentralCrossRefGoogle Scholar
- 40.Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557–565PubMedCrossRefGoogle Scholar
- 42.Moradian S, Voelker N, Brown C, Liu G, Howell D (2018) Effectiveness of Internet-based interventions in managing chemotherapy-related symptoms in patients with cancer: a systematic literature review. Support Care Cancer 26(2):361–374Google Scholar